ARCHIVES

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests

June 5, 1992

Professional Societies: ONS To Study Trends In Health Economics Affecting Nursing

October 4, 1996

DRCCA Bard Group Recommends No New Nationwide Screening Program Until More Research Is Done

November 5, 1982

Women Radiated For Wilms’ At Risk For Complications In Pregnancy, Study Finds

May 31, 2002

Congresswoman Urges Increased Funding For Cancer information Service

August 11, 1989

1.7% Cut Expected in NCI Budget Under Deficit Agreement

November 24, 1989